BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 18210352)

  • 1. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
    Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
    J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
    Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
    Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of intraoperative ultra low-field magnetic resonance imaging in glioma surgery.
    Senft C; Seifert V; Hermann E; Franz K; Gasser T
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):257-66; discussion 266-7. PubMed ID: 18981831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliomas: Motexafin Gadolinium-enhanced Molecular MR Imaging and Optical Imaging for Potential Intraoperative Delineation of Tumor Margins.
    Qiu L; Zhang F; Shi Y; Bai Z; Wang J; Li Y; Lee D; Ingraham C; Feng X; Yang X
    Radiology; 2016 May; 279(2):400-9. PubMed ID: 26599802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution MRI of deep-seated atherosclerotic arteries using motexafin gadolinium.
    Brushett C; Qiu B; Atalar E; Yang X
    J Magn Reson Imaging; 2008 Jan; 27(1):246-50. PubMed ID: 18050320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
    Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
    Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laparoscopic and general surgery guided by open interventional magnetic resonance].
    Lauro A; Gould SW; Cirocchi R; Giustozzi G; Darzi A
    Minerva Chir; 2004 Oct; 59(5):507-16. PubMed ID: 15494679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography.
    Kanick SC; Eiseman JL; Joseph E; Guo J; Parker RS
    J Photochem Photobiol B; 2007 Sep; 88(2-3):90-104. PubMed ID: 17604637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
    Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
    Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.
    Ford JM; Seiferheld W; Alger JR; Wu G; Endicott TJ; Mehta M; Curran W; Phan SC
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):831-8. PubMed ID: 17560737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI measurement of the uptake and retention of motexafin gadolinium in glioblastoma multiforme and uninvolved normal human brain.
    Wu GN; Ford JM; Alger JR
    J Neurooncol; 2006 Mar; 77(1):95-103. PubMed ID: 16547607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.
    Ewing JR; Brown SL; Lu M; Panda S; Ding G; Knight RA; Cao Y; Jiang Q; Nagaraja TN; Churchman JL; Fenstermacher JD
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):310-20. PubMed ID: 16079791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.